{
	"CHB_news": [
		{
			"stock": "ZLAB",
			"news_titles": [
				"Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China",
				"Zai Lab Announces Participation in September Investor Conferences",
				"Penn downgraded, Roblox upgraded: Wall Street's top analyst calls",
				"Zai Lab Announces Second Quarter 2023Â Financial Results and Corporate Updates",
				"12 Stocks with Biggest Upside Potential According to Analysts",
				"Zai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023",
				"JAMA Oncology Publishes Data from Zai Lab Study Demonstrating Significant Reduction in Disease Progression or Death with ZEJULA (Niraparib) Maintenance Therapy in Broad Population of Advanced Ovarian Cancer Patients",
				"Zai Lab and argenx Report Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy"
			]
		}
	]
}